159 related articles for article (PubMed ID: 16761419)
1. [P53 codon 72 polymorphism in cervical cancers and its correlation with HPV16,18E6].
Hou MM; Xi MR; Cao ZY; Yang KX; Sun ZL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 May; 37(3):404-7. PubMed ID: 16761419
[TBL] [Abstract][Full Text] [Related]
2. Analysis of p53 codon 72 polymorphism and its association with human papillomavirus 16 and 18 E6 in Chinese cervical lesions.
Min-min H; Ming-rong X; Ze-yi C; Kai-xuan Y; Zhi-lin S
Int J Gynecol Cancer; 2006; 16(6):2004-8. PubMed ID: 17177838
[TBL] [Abstract][Full Text] [Related]
3. Codon 72 polymorphism of p53 as a risk factor for patients with human papillomavirus-associated squamous intraepithelial lesions and invasive cancer of the uterine cervix.
Yamashita T; Yaginuma Y; Saitoh Y; Kawai K; Kurakane T; Hayashi H; Ishikawa M
Carcinogenesis; 1999 Sep; 20(9):1733-6. PubMed ID: 10469618
[TBL] [Abstract][Full Text] [Related]
4. G2 checkpoint in uterine cervical cancer with HPV 16 E6 according to p53 polymorphism and its screening value.
Cho NH; Lim SY; Kim YT; Kim D; Kim YS; Kim JW
Gynecol Oncol; 2003 Jul; 90(1):15-22. PubMed ID: 12821336
[TBL] [Abstract][Full Text] [Related]
5. Analysis of human papillomavirus type 16 E6 variants in relation to p53 codon 72 polymorphism genotypes in cervical carcinogenesis.
van Duin M; Snijders PJ; Vossen MT; Klaassen E; Voorhorst F; Verheijen RH; Helmerhorst TJ; Meijer CJ; Walboomers JM
J Gen Virol; 2000 Feb; 81(Pt 2):317-25. PubMed ID: 10644829
[TBL] [Abstract][Full Text] [Related]
6. HPV16 E6 mutations and p53 codon72 polymorphism among women with cervical intraepithelial neoplasia 2 and 3 in China.
Piao J; You K; Guo Y; Zhang Y; Li Z; Geng L
Eur J Gynaecol Oncol; 2016; 37(5):649-652. PubMed ID: 29787003
[TBL] [Abstract][Full Text] [Related]
7. Polymorphism at codon 72 of p53, human papillomavirus, and cervical cancer in South India.
Pillai MR; Sreevidya S; Pollock BH; Jayaprakash PG; Herman B
J Cancer Res Clin Oncol; 2002 Nov; 128(11):627-31. PubMed ID: 12458344
[TBL] [Abstract][Full Text] [Related]
8. HPV16/18 prevalence in cervical lesions/cancers and p53 genotypes in cervical cancer patients from India.
Saranath D; Khan Z; Tandle AT; Dedhia P; Sharma B; Contractor R; Shrivastava S; Dinshaw K
Gynecol Oncol; 2002 Aug; 86(2):157-62. PubMed ID: 12144822
[TBL] [Abstract][Full Text] [Related]
9. HPV16 E6*II gene expression in intraepithelial cervical lesions as an indicator of neoplastic grade: a pilot study.
Pastuszak-Lewandoska D; Bartosińska-Dyc A; Migdalska-Sęk M; Czarnecka KH; Nawrot E; Domańska D; Szyłło K; Brzeziańska E
Med Oncol; 2014 Mar; 31(3):842. PubMed ID: 24436016
[TBL] [Abstract][Full Text] [Related]
10. Correlation of E6 and E7 levels in high-risk HPV16 type cervical lesions with CCL20 and Langerhans cells.
Jiang B; Xue M
Genet Mol Res; 2015 Sep; 14(3):10473-81. PubMed ID: 26400278
[TBL] [Abstract][Full Text] [Related]
11. A novel MLL5 isoform that is essential to activate E6 and E7 transcription in HPV16/18-associated cervical cancers.
Yew CW; Lee P; Chan WK; Lim VK; Tay SK; Tan TM; Deng LW
Cancer Res; 2011 Nov; 71(21):6696-707. PubMed ID: 21908553
[TBL] [Abstract][Full Text] [Related]
12. Viral DNA load, physical status and E2/E6 ratio as markers to grade HPV16 positive women for high-grade cervical lesions.
Cricca M; Morselli-Labate AM; Venturoli S; Ambretti S; Gentilomi GA; Gallinella G; Costa S; Musiani M; Zerbini M
Gynecol Oncol; 2007 Sep; 106(3):549-57. PubMed ID: 17568661
[TBL] [Abstract][Full Text] [Related]
13. Uneven distribution of HPV 16 E6 prototype and variant (L83V) oncoprotein in cervical neoplastic lesions.
Andersson S; Alemi M; Rylander E; Strand A; Larsson B; Sällström J; Wilander E
Br J Cancer; 2000 Aug; 83(3):307-10. PubMed ID: 10917543
[TBL] [Abstract][Full Text] [Related]
14. HPV prevalence, E6 sequence variation and physical state of HPV16 isolates from patients with cervical cancer in Sichuan, China.
Qiu AD; Wu EQ; Yu XH; Jiang CL; Jin YH; Wu YG; Chen Y; Chen Y; Shan YM; Zhang GN; Fan Y; Zha X; Kong W
Gynecol Oncol; 2007 Jan; 104(1):77-85. PubMed ID: 16970982
[TBL] [Abstract][Full Text] [Related]
15. Human papilloma virus early proteins E6 (HPV16/18-E6) and the cell cycle marker P16 (INK4a) are useful prognostic markers in uterine cervical carcinomas in Qassim Region--Saudi Arabia.
Omran OM; AlSheeha M
Pathol Oncol Res; 2015 Jan; 21(1):157-66. PubMed ID: 24925218
[TBL] [Abstract][Full Text] [Related]
16. HPV 16-E6-mediated degradation of intrinsic p53 is compensated by upregulation of p53 gene expression in normal cervical keratinocytes.
Kawamata Y; Mitsuhashi A; Unno Y; Kado S; Shino Y; Uesugi K; Eguchi O; Ishii J; Seki K; Sekiya S; Shirasawa H
Int J Oncol; 2002 Sep; 21(3):561-7. PubMed ID: 12168100
[TBL] [Abstract][Full Text] [Related]
17. HPV-related cancer susceptibility and p53 codon 72 polymorphism.
Gustafsson AC; Guo Z; Hu X; Ahmadian A; Brodin B; Nilsson A; Pontén J; Pontén F; Lundeberg J
Acta Derm Venereol; 2001 May; 81(2):125-9. PubMed ID: 11501650
[TBL] [Abstract][Full Text] [Related]
18. p53 codon 72 polymorphism and risk of intra-epithelial and invasive cervical neoplasia in Greek women.
Agorastos T; Lambropoulos AF; Constantinidis TC; Kotsis A; Bontis JN
Eur J Cancer Prev; 2000 Apr; 9(2):113-8. PubMed ID: 10830578
[TBL] [Abstract][Full Text] [Related]
19. Codon 72 polymorphism of p53 and HPV type 16 E6 variants as risk factors for patients with squamous epithelial lesion of the uterine cervix.
Burroni E; Bisanzi S; Sani C; Puliti D; Carozzi F
J Med Virol; 2013 Jan; 85(1):83-90. PubMed ID: 23124863
[TBL] [Abstract][Full Text] [Related]
20. Association of p53 codon 72 genotypes and clinical outcome in human papillomavirus-infected lung cancer patients.
Chen SP; Hsu NY; Wu JY; Chen CY; Chou MC; Lee H; Cheng YW
Ann Thorac Surg; 2013 Apr; 95(4):1196-203. PubMed ID: 23522190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
